Cabaletta Bio (CABA) Other Gross PP&E Adjustments (2018 - 2025)
Cabaletta Bio's quarterly Other Gross PP&E Adjustments came in at -$19.9 million in Q4 2025, down 129.29% year-on-year from $68.0 million in Q4 2024, and down 25.07% quarter-over-quarter from -$15.9 million in Q3 2025.
Cabaletta Bio has reported Other Gross PP&E Adjustments for 8 years, with the latest figure at -$19.9 million in Q4 2025.
- For the quarter ending Q4 2025, Other Gross PP&E Adjustments fell 129.29% year-over-year to -$19.9 million; the trailing twelve-month figure through Dec 2025 stood at -$19.9 million (down 129.29% YoY), and the FY2025 full-year result was -$19.9 million, down 129.29% from the prior year.
- Other Gross PP&E Adjustments for Q4 2025 stood at -$19.9 million, down from -$15.9 million in the prior quarter.
- The five-year high for Other Gross PP&E Adjustments was $13000.0 in Q4 2021, with the low at -$19.9 million in Q4 2025.
- Average Other Gross PP&E Adjustments over 5 years is -$8.2 million, with a median of -$5.7 million recorded in 2024.
- Year-over-year, Other Gross PP&E Adjustments tumbled 29976.92% in 2022 and rose 29.35% in 2025.
- Tracing CABA's Other Gross PP&E Adjustments over 5 years: stood at $13000.0 in 2021, then plunged by 29976.92% to -$3.9 million in 2022, then declined by 19.46% to -$4.6 million in 2023, then tumbled by 87.28% to -$8.7 million in 2024, then tumbled by 129.29% to -$19.9 million in 2025.
- The last three Other Gross PP&E Adjustments figures came in at -$19.9 million (Q4 2025), -$15.9 million (Q3 2025), and -$16.7 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Gross PP&E Adjustments (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -83,048.00 |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | -60,691.22 |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -285.20 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -892,000.00 |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | -1.69 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | -189.30 Mn |
| 10 | Cabaletta Bio | 194.84 Mn | 61.24 Mn | - | -19.93 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -19.93 Mn |
| Dec 31, 2025 | -19.93 Mn |
| Sep 30, 2025 | -15.93 Mn |
| Sep 30, 2025 | -15.93 Mn |
| Jun 30, 2025 | -16.69 Mn |
| Jun 30, 2025 | -16.69 Mn |
| Mar 31, 2025 | -5.43 Mn |
| Mar 31, 2025 | -5.43 Mn |
| Dec 31, 2024 | -8.69 Mn |
| Dec 31, 2024 | -8.69 Mn |
| Sep 30, 2024 | -13.60 Mn |
| Sep 30, 2024 | -13.60 Mn |
| Jun 30, 2024 | -5.93 Mn |
| Jun 30, 2024 | -5.93 Mn |
| Mar 31, 2024 | -7.69 Mn |
| Mar 31, 2024 | -7.69 Mn |
| Dec 31, 2023 | -4.64 Mn |
| Dec 31, 2023 | -4.64 Mn |
| Sep 30, 2023 | -4.14 Mn |
| Sep 30, 2023 | -4.14 Mn |
| Jun 30, 2023 | -4.08 Mn |
| Jun 30, 2023 | -4.08 Mn |
| Mar 31, 2023 | -4.54 Mn |
| Mar 31, 2023 | -4.54 Mn |
| Dec 31, 2022 | -3.88 Mn |
| Dec 31, 2022 | -3.88 Mn |
| Dec 31, 2021 | 13,000.00 |
| Dec 31, 2021 | 13,000.00 |
| Dec 31, 2020 | 105,000.00 |
| Dec 31, 2020 | 105,000.00 |
| Dec 31, 2019 | 655,000.00 |
| Dec 31, 2019 | 655,000.00 |
| Dec 31, 2018 | -17,000.00 |
| Dec 31, 2018 | -17,000.00 |